The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government
Bradley Moore, CEO of GCAC discusses how artificial intelligence and blockchain (trusted data) solve the paradox of limited medical cannabis data and anecdotal user information
Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
The current state of metabolomics research and application in Acute Myeloid Leukaemia is placed under the spotlight by Bradley Stockard and Jatinder Lamba from Department of Pharmacotherapy and Translational Research, University of Florida
Anna Knuuttila, Senior Scientist and Kaisa Helminen, CEO of Fimmic explain how artificial intelligence (AI) empowers pathologists when it comes to cancer care.
Michele Calabro’, European Health Management Association Policy and Communications Manager explains antimicrobial resistance (AMR), focussing on why Europe still needs to talk about a preventable crisis that could cause more deaths than cancer
Writer, medical cannabis patient, a grower and budtender for GrassRoots Medicinal in Squamish, Caleb McMillan, provides his thoughts on cannabis developments in North America today
Acting Deputy Under Secretary for Food Safety at the United States Department of Agriculture (USDA), Carmen Rottenberg explains how the Food Safety and Inspection Service protects Americans from foodborne illness
Professor of Developmental Mechanics at the Department of Genetics, University of Cambridge, Alfonso Martinez Arias shares his expert view on Organoids, within the field of developmental biology.
Board Member for Canadians for Fair Access to Medical Marijuana (CFAMM), Peter Thurley, shares his views on medical cannabis advocacy and education issues
Managing Director of The Cancer Drug Development Forum, Prof. H. Zwierzina reveals his opinions on the current and future challenges of personalised cancer therapy, including the need for biomarkers.
Ciara Morrison, Head of HR and Talent at Instant Offices looks into the importance of mental health awareness in the workplace and how businesses can prioritise and promote a healthy work-life balance
